Hikichi Eye Clinic, Sapporo, Japan; and.
Carl Zeiss Meditec Co, Ltd, Tokyo, Japan.
Retina. 2020 Nov;40(11):2158-2165. doi: 10.1097/IAE.0000000000002745.
To investigate predictors of recurrent exudation in choroidal neovascularization (CNV) of age-related macular degeneration on optical coherence tomography angiography (OCTA) images during an anti-vascular endothelium growth factor therapy-free period.
Optical coherence tomography angiography images of 41 eyes of 41 patients with more than a 3-year history of anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration at the study baseline were evaluated retrospectively. The patients thereafter had a treatment-free period exceeding 6 months under an as-needed regimen and could be followed for an additional 6 months.
The square root of the CNV area in 19 eyes with recurrence during the second 6-month period enlarged significantly (P = 0.036) from 2.31 ± 0.81 (mean ± SD) to 2.86 ± 0.87 mm during the treatment-free period but not in the 22 eyes without a recurrence. The percentages of branching with tiny vessels (42%) and peripheral arcades at the CNV termini (42%) were significantly (P < 0.001, respectively) higher in the recurrence group compared with the group in which the CNV was no longer active (14% and 5%, respectively).
Choroidal neovascularization enlargement and features may guide treatment timing in eyes with exudative-free periods.
在抗血管内皮生长因子治疗停药期间,通过光学相干断层扫描血管造影(OCTA)图像,研究年龄相关性黄斑变性脉络膜新生血管(CNV)反复渗出的预测因子。
回顾性分析 41 例年龄相关性黄斑变性新生血管患者的 41 只眼,这些患者在研究基线时有超过 3 年的抗血管内皮生长因子治疗史。此后,患者采用按需治疗方案,停药时间超过 6 个月,并可再随访 6 个月。
在第 2 个 6 个月期间复发的 19 只眼中,CNV 区域的平方根在治疗停药期间从 2.31±0.81(均数±标准差)显著增大至 2.86±0.87mm(P=0.036),但在没有复发的 22 只眼中没有增大。在复发组中,分支状微小血管(42%)和 CNV 末端周边环(42%)的比例明显高于 CNV 不再活跃的组(分别为 14%和 5%)(均 P<0.001)。
CNV 扩大和特征可能有助于指导有渗出液期的眼睛的治疗时机。